Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
Clinical trial NCT03038308 · COMPLETED
Trial details
- NCT number
- NCT03038308
- Sponsor
- Columbia University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-16
- Primary completion
- 2020-11-05
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.